Page last updated: 2024-09-05

dapivirine and baricitinib

dapivirine has been researched along with baricitinib in 1 studies

Compound Research Comparison

Studies
(dapivirine)
Trials
(dapivirine)
Recent Studies (post-2010)
(dapivirine)
Studies
(baricitinib)
Trials
(baricitinib)
Recent Studies (post-2010) (baricitinib)
1966416065395631

Protein Interaction Comparison

ProteinTaxonomydapivirine (IC50)baricitinib (IC50)
Cyclin-G-associated kinaseHomo sapiens (human)0.136
Tyrosine-protein kinase JAK2Homo sapiens (human)0.1233
Tyrosine-protein kinase JAK1Homo sapiens (human)0.0739
Non-receptor tyrosine-protein kinase TYK2Homo sapiens (human)0.1565
Tyrosine-protein kinase JAK3Homo sapiens (human)0.4477
AP2-associated protein kinase 1Homo sapiens (human)0.017

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M1

Other Studies

1 other study(ies) available for dapivirine and baricitinib

ArticleYear
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
    Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3

    Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries

2023